NewBiologix operates as a technology innovation company.
NewBiologix has raised $50.3M in total funding. The most recent round was Series A. The last funding was announced in May 2023.
NewBiologix's investors include Recipharm Venture Fund, Igor Fish, Nicolas Mermod.
NewBiologix is headquartered in Epalinges, Switzerland.
NewBiologix operates as a technology innovation company.
NewBiologix is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NewBiologix — Funding & Investors." VCBacked, May 11, 2023, https://www.vcbacked.co/company/newbiologix. Accessed August 15, 2026.
VCBacked. (2023). NewBiologix — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/newbiologix
{{cite web |title=NewBiologix — Funding & Investors |url=https://www.vcbacked.co/company/newbiologix |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated